What's at stake in the EU, AstraZeneca vaccine supply dispute

  • 📰 ABC
  • ⏱ Reading Time:
  • 34 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 17%
  • Publisher: 51%

United States Headlines News

United States Latest News,United States Headlines

Top EU officials have expressed 'deep dissatisfaction' and mulled legal action against the British-Swedish pharmaceutical company AstraZeneca, after reports emerged that the vaccine supplier would provide 60% fewer doses in the first quarter of 2021.

"Last Friday, the company AstraZeneca surprisingly informed the Commission and the European Union Member States that it intends to supply considerably fewer doses in the coming weeks than agreed and announced," she said."The European Union wants to know exactly which doses have been produced by AstraZeneca and where exactly so far and if or to whom they have been delivered."

In a statement on Friday, AstraZeneca said that while there would be no delay once the vaccine was approved in the EU,"initial volumes will be lower than originally anticipated due to reduced yields at a manufacturing site within our European supply chain." In her statement on Monday, Kyriakides said the EU was requesting the order, which was"pre-paid," be"delivered as soon as possible."The CEO of AstraZeneca, Pascal Soriot, spoke to European Commission President Ursula Von der Leyen on Monday and stressed the company was"doing everything it can to bring its vaccine to millions of Europeans as soon as possible."

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 471. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.